Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Memorial Sloan Kettering Cancer Center
Related studies linked through entity extraction aliases.
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Alanosine in Treating Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Polyglutamate Camptothecin in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1